Published in World J Gastroenterol on November 07, 2014
Polyunsaturated Fatty Acids and Their Derivatives: Therapeutic Value for Inflammatory, Functional Gastrointestinal Disorders, and Colorectal Cancer. Front Pharmacol (2016) 0.84
Molecular aspects of intestinal calcium absorption. World J Gastroenterol (2015) 0.83
Preventing aggressive prostate cancer with proven cardiovascular disease preventive methods. Asian J Androl (2015) 0.81
Mouse models of colorectal cancer as preclinical models. Bioessays (2015) 0.78
Physical activity and risk of rheumatoid arthritis in women: a population-based prospective study. Arthritis Res Ther (2015) 0.75
Insulin-Like Growth Factor-2 Is Induced Following 5-Aminolevulinic Acid-Mediated Photodynamic Therapy in SW620 Human Colon Cancer Cell Line. Int J Mol Sci (2015) 0.75
Natural Agents Used in Chemoprevention of Aerodigestive and GI Cancers. Curr Pharmacol Rep (2016) 0.75
Association between ischemic heart disease and colorectal neoplasm: a systematic review and meta-analysis. Springerplus (2016) 0.75
Colorectal cancer, screening and primary care: A mini literature review. World J Gastroenterol (2017) 0.75
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial. JAMA (2002) 80.37
The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med (1996) 23.76
Effect of selenium and vitamin E on risk of prostate cancer and other cancers: the Selenium and Vitamin E Cancer Prevention Trial (SELECT). JAMA (2008) 13.35
Effect of daily aspirin on long-term risk of death due to cancer: analysis of individual patient data from randomised trials. Lancet (2010) 13.13
Long-term effect of aspirin on colorectal cancer incidence and mortality: 20-year follow-up of five randomised trials. Lancet (2010) 11.00
A randomized trial of aspirin to prevent colorectal adenomas. N Engl J Med (2003) 9.18
Calcium plus vitamin D supplementation and the risk of colorectal cancer. N Engl J Med (2006) 8.73
Folic acid for the prevention of colorectal adenomas: a randomized clinical trial. JAMA (2007) 7.93
Celecoxib for the prevention of sporadic colorectal adenomas. N Engl J Med (2006) 7.62
A randomized trial of aspirin to prevent colorectal adenomas in patients with previous colorectal cancer. N Engl J Med (2003) 6.99
Long-term effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet (2011) 6.77
Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group. N Engl J Med (2000) 6.53
Celecoxib for the prevention of colorectal adenomatous polyps. N Engl J Med (2006) 6.15
A clinical trial of antioxidant vitamins to prevent colorectal adenoma. Polyp Prevention Study Group. N Engl J Med (1994) 5.98
Difluoromethylornithine plus sulindac for the prevention of sporadic colorectal adenomas: a randomized placebo-controlled, double-blind trial. Cancer Prev Res (Phila) (2008) 5.82
Estrogen plus progestin and colorectal cancer in postmenopausal women. N Engl J Med (2004) 5.65
The use of aspirin for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force. Ann Intern Med (2007) 4.74
Meat, fish, and colorectal cancer risk: the European Prospective Investigation into cancer and nutrition. J Natl Cancer Inst (2005) 4.45
The epidemiology of vitamin D and cancer incidence and mortality: a review (United States). Cancer Causes Control (2005) 4.29
Calcium supplements for the prevention of colorectal adenomas. Calcium Polyp Prevention Study Group. N Engl J Med (1999) 4.11
Lack of effect of a high-fiber cereal supplement on the recurrence of colorectal adenomas. Phoenix Colon Cancer Prevention Physicians' Network. N Engl J Med (2000) 4.08
Aspirin and folic acid for the prevention of recurrent colorectal adenomas. Gastroenterology (2007) 4.06
Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the U.S. Preventive Services Task Force. Ann Intern Med (2011) 3.71
Folate and carcinogenesis: an integrated scheme. J Nutr (2000) 3.57
Dietary fibre in food and protection against colorectal cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC): an observational study. Lancet (2003) 3.53
A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas. Gastroenterology (2006) 3.35
Primary prevention of colorectal cancer. Gastroenterology (2010) 3.20
Aspirin for the chemoprevention of colorectal adenomas: meta-analysis of the randomized trials. J Natl Cancer Inst (2009) 3.15
Physical activity and colon cancer prevention: a meta-analysis. Br J Cancer (2009) 3.13
Obesity and cancer. Oncologist (2010) 3.01
The risk of cancer in users of statins. J Clin Oncol (2004) 3.01
A temporal association between folic acid fortification and an increase in colorectal cancer rates may be illuminating important biological principles: a hypothesis. Cancer Epidemiol Biomarkers Prev (2007) 2.91
Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies. JAMA (2005) 2.76
Physical activity and risks of proximal and distal colon cancers: a systematic review and meta-analysis. J Natl Cancer Inst (2012) 2.71
Calcium intake and risk of colon cancer in women and men. J Natl Cancer Inst (2002) 2.59
Red and processed meat and colorectal cancer incidence: meta-analysis of prospective studies. PLoS One (2011) 2.55
Dairy foods, calcium, and colorectal cancer: a pooled analysis of 10 cohort studies. J Natl Cancer Inst (2004) 2.54
Prospective study of fruit and vegetable consumption and incidence of colon and rectal cancers. J Natl Cancer Inst (2000) 2.46
Postmenopausal hormone therapy and the risk of colorectal cancer: a review and meta-analysis. Am J Med (1999) 2.42
Vitamin B6 and risk of colorectal cancer: a meta-analysis of prospective studies. JAMA (2010) 2.39
Colorectal cancer risk, chronic illnesses, operations, and medications: case control results from the Melbourne Colorectal Cancer Study. Cancer Res (1988) 2.28
Eicosapentaenoic acid reduces rectal polyp number and size in familial adenomatous polyposis. Gut (2010) 2.23
Folate intake and colorectal cancer risk: a meta-analytical approach. Int J Cancer (2005) 2.11
Reduced risk of colorectal cancer with use of oral bisphosphonates: a systematic review and meta-analysis. J Clin Oncol (2012) 2.09
Vitamin D and prevention of colorectal cancer. J Steroid Biochem Mol Biol (2005) 2.01
Chemoprevention of colorectal cancer. N Engl J Med (2000) 1.98
Postmenopausal hormone use and risk for colorectal cancer and adenoma. Ann Intern Med (1998) 1.96
Dietary fibre and colorectal adenoma in a colorectal cancer early detection programme. Lancet (2003) 1.95
Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy. PLoS One (2012) 1.93
Fruit, vegetables, dietary fiber, and risk of colorectal cancer. J Natl Cancer Inst (2001) 1.90
Alcohol drinking and colorectal cancer risk: an overall and dose-response meta-analysis of published studies. Ann Oncol (2011) 1.84
Use of bisphosphonates and reduced risk of colorectal cancer. J Clin Oncol (2011) 1.84
Colon cancer and dietary fat, phosphate, and calcium: a hypothesis. J Natl Cancer Inst (1984) 1.74
Vitamin D and cancer. J Steroid Biochem Mol Biol (2006) 1.72
Safety and tolerability of cholesterol lowering with simvastatin during 5 years in the Scandinavian Simvastatin Survival Study. Arch Intern Med (1996) 1.68
Fruits, vegetables, and colon cancer risk in a pooled analysis of 14 cohort studies. J Natl Cancer Inst (2007) 1.57
Role of supplemental calcium in the recurrence of colorectal adenomas: a metaanalysis of randomized controlled trials. Am J Gastroenterol (2005) 1.55
Diet and risk of colorectal cancer in a cohort of Finnish men. Cancer Causes Control (1999) 1.50
Nonlinear reduction in risk for colorectal cancer by fruit and vegetable intake based on meta-analysis of prospective studies. Gastroenterology (2011) 1.50
Folate intake and risk of colorectal cancer and adenoma: modification by time. Am J Clin Nutr (2011) 1.45
Whole grain consumption and risk of colorectal cancer: a population-based cohort of 60,000 women. Br J Cancer (2005) 1.39
Folate, vitamin B6, multivitamin supplements, and colorectal cancer risk in women. Am J Epidemiol (2005) 1.36
Dietary factors and risk of colon cancer in Shanghai, China. Cancer Epidemiol Biomarkers Prev (2003) 1.31
Dairy products and colorectal cancer risk: a systematic review and meta-analysis of cohort studies. Ann Oncol (2011) 1.31
A randomized trial on folic acid supplementation and risk of recurrent colorectal adenoma. Am J Clin Nutr (2009) 1.28
Aspirin and other non-steroidal anti-inflammatory drugs and risk of colorectal cancer: a Danish cohort study. Cancer Causes Control (2009) 1.25
A meta-analysis of hormone replacement therapy and colon cancer in women. Cancer Epidemiol Biomarkers Prev (1998) 1.22
Fish consumption and colorectal cancer risk in humans: a systematic review and meta-analysis. Am J Med (2012) 1.21
Dietary folate, methionine, riboflavin, and vitamin B-6 and risk of sporadic colorectal cancer. J Nutr (2008) 1.12
Body mass index at different adult ages, weight change, and colorectal cancer risk in the National Institutes of Health-AARP Cohort. Am J Epidemiol (2012) 1.09
Folate and vitamin B6 intake and risk of colon cancer in relation to p53 expression. Gastroenterology (2008) 1.06
Nonsteroidal anti-inflammatory drug use after 3 years of aspirin use and colorectal adenoma risk: observational follow-up of a randomized study. J Natl Cancer Inst (2009) 1.05
Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. Lancet Oncol (2012) 1.01
A prospective study of bisphosphonate use and risk of colorectal cancer. J Clin Oncol (2012) 1.00
Smoking, folate and methylenetetrahydrofolate reductase status as interactive determinants of adenomatous and hyperplastic polyps of colorectum. Am J Med Genet (2001) 1.00
Estrogen plus progestin and colorectal cancer incidence and mortality. J Clin Oncol (2012) 1.00
Meta-analysis: antioxidant supplements for primary and secondary prevention of colorectal adenoma. Aliment Pharmacol Ther (2006) 0.98
A pooled analysis of smoking and colorectal cancer: timing of exposure and interactions with environmental factors. Cancer Epidemiol Biomarkers Prev (2012) 0.97
Can we consider zoledronic acid a new antitumor agent? Recent evidence in clinical setting. Curr Cancer Drug Targets (2010) 0.95
Mechanism of action of vitamin D and the vitamin D receptor in colorectal cancer prevention and treatment. Rev Endocr Metab Disord (2012) 0.94
Exposure to bisphosphonates and risk of colorectal cancer: a population-based nested case-control study. Cancer (2011) 0.93
Nutrition chemoprevention of gastrointestinal cancers: a critical review. Nutr Rev (1996) 0.93
The bisphosphonate zoledronic acid inhibits the growth of HCT-116 colon carcinoma cells and induces tumor cell apoptosis. Apoptosis (2008) 0.93
Prevention by daily soluble aspirin of colorectal adenoma recurrence: 4-year results of the APACC randomised trial. Gut (2011) 0.90
A case-control study of diet and rectal cancer in western New York. Am J Epidemiol (1990) 0.90
Physical activity and gastrointestinal cancer prevention. Recent Results Cancer Res (2011) 0.89
Resistant starch and colorectal neoplasia. J AOAC Int (2004) 0.87
Vegetable and animal products as determinants of colon cancer risk in Dutch men and women. Cancer Causes Control (1995) 0.86
Epidemiology of fibre, resistant starch and colorectal cancer. Eur J Cancer Prev (1995) 0.85
Fruit, vegetables, and folate: cultivating the evidence for cancer prevention. Gastroenterology (2011) 0.83
Fiber intake and risk of colorectal cancer. Cancer Epidemiol Biomarkers Prev (1998) 0.79
Antioxidant vitamin supplements: update of their potential benefits and possible risks. Drug Saf (1999) 0.78
Long-term use of nonsteroidal antiinflammatory drugs and the risk of colorectal adenomas. The Colorectal Adenoma Study Group. Digestion (2000) 0.77
The effects of sex steroids on colon carcinogenesis. Anticancer Drugs (1990) 0.77